FDA Inspection 1172077 — GC Hanford Manufacturing Company

GC Hanford Manufacturing Company — FEI 1310197

The FDA completed an inspection of GC Hanford Manufacturing Company on Jun 17, 2022 in Syracuse, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Veterinary.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 17, 2022
Fiscal Year
2022
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Syracuse, NY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
358521 CFR 211.110(a)Control procedures to monitor and validate performance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.